Department of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.
J Funct Biomater. 2015 Jan 22;6(1):50-65. doi: 10.3390/jfb6010050.
Corneal blindness affects over 10 million people worldwide and current treatment strategies often involve replacement of the defective layer with healthy tissue. Due to a worldwide donor cornea shortage and the absence of suitable biological scaffolds, recent research has focused on the development of tissue engineering techniques to create alternative therapies. This review will detail how we have refined the simple engineering technique of plastic compression of collagen to a process we now call Real Architecture for 3D Tissues (RAFT). The RAFT production process has been standardised, and steps have been taken to consider Good Manufacturing Practice compliance. The evolution of this process has allowed us to create biomimetic epithelial and endothelial tissue equivalents suitable for transplantation and ideal for studying cell-cell interactions in vitro.
角膜盲症影响着全球超过 1000 万人,目前的治疗策略通常涉及用健康组织替代有缺陷的组织。由于全球供体角膜短缺和缺乏合适的生物支架,最近的研究集中在开发组织工程技术来创造替代疗法上。本综述将详细介绍我们如何将简单的胶原塑料压缩工程技术细化为我们现在称之为三维组织的真实架构(RAFT)的过程。RAFT 生产过程已经标准化,并采取了步骤来考虑符合良好生产规范。这一过程的发展使我们能够创造出适合移植的仿生上皮和内皮组织等效物,非常适合体外研究细胞-细胞相互作用。